Clinical Trial Update: ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness [Phase 4]

View source ↗

Summary

A Phase 4 trial update on Abilify (aripiprazole) for long-term effectiveness in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Korea Otsuka International Asia Arab | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED